卖什么
AI Agents for Pharma Drug Launches
商业模式拆解
买家：谁掌握预算？
未核实Heads of Global Market Access / Pricing & Market Access at pharma companies.
触发点：什么让他们现在购买？
未核实Upcoming drug launch or pricing decision requiring analog research, HTA outcomes and cross-country price benchmarking that currently takes weeks of manual research.
工作流：什么输入变成什么输出？
Ask plain-language questions over a database of clinical, regulatory, HTA and pricing data; run analog research, disease landscaping, competitor monitoring, price comparison and launch sequence analysis with every figure traced to source; or commission expert-written reports.
经济账：省了什么，怎么收费？
Software platform plus expert-led services; value claim is turning weeks of manual research into answers in minutes; 0% churn claimed since launch.
渠道：怎么接触到客户？
Demo-led sales (Book a demo) and scoped service projects (Scope your project) to large pharma.
融资历史与报道
| 融资日期 | 轮次 | 金额 | 投资方 | 来源 |
|---|---|---|---|---|
| — | YC 2022 冬季 | — | Y Combinator | ycombinator.com |
档案汇总自公开报道和公司官网。商业模式部分是 MaxBC 对这些材料的解读，不是已确认的事实；未知之处留空，不作猜测。 更新于 2026-10-12.